News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Enzymatics Inc. Announces New England Biolabs, Inc. Drops Patent 5,670,637 Infringement Claim


6/12/2013 10:23:43 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BEVERLY, Mass.--(BUSINESS WIRE)--Enzymatics, Inc., a rapidly growing provider of molecular biology reagents, today announced that patent infringement claims filed against the company by New England BioLabs (NEB) have been significantly narrowed. NEB has completely withdrawn the claim that Enzymatics infringed on U.S. Patent No. 5,670,637 (‘637) and has conceded that U.S. Patent No. 5,874,557 (‘557) has expired, withdrawing its request for injunctive relief.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES